RNA editing modulates human hepatic aryl hydrocarbon receptor expression by creating MicroRNA recognition sequence

Journal of Biological Chemistry

Volumn 291, Issue 2, 2016, Pages 894-903

  Nakano, Masataka ^a   Fukami, Tatsuki ^a   Gotoh, Saki ^a   Takamiya, Masataka ^b   Aoki, Yasuhiro ^b,c   Nakajima, Miki ^a  

^a KANAZAWA UNIVERSITY   (Japan)

^b IWATE MEDICAL UNIVERSITY   (Japan)

^c NAGOYA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICAL SCIENCES   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ENZYMES; HYDROCARBONS; NUCLEIC ACIDS; PROTEINS;

ADENOSINE DEAMINASES; ARYL HYDROCARBON RECEPTOR; HEPATOCELLULAR CARCINOMA; INTER-INDIVIDUAL DIFFERENCES; POST-TRANSCRIPTIONAL; RECOGNITION SEQUENCE; UNTRANSLATED REGIONS; XENOBIOTIC METABOLISM;

RNA;

ADENOSINE DEAMINASE; ADENOSINE DEAMINASE ACTING ON RNA 1; AROMATIC HYDROCARBON RECEPTOR; CYTOCHROME P450 1A1; LIGAND; LIVER PROTEIN; MICRORNA; MICRORNA 378; UNCLASSIFIED DRUG; 3' UNTRANSLATED REGION; ADAR1 PROTEIN, HUMAN; ADARB1 PROTEIN, HUMAN; AHR PROTEIN, HUMAN; BASIC HELIX LOOP HELIX TRANSCRIPTION FACTOR; MESSENGER RNA; MIRN378 MICRORNA, HUMAN; RNA BINDING PROTEIN;

3' UNTRANSLATED REGION; ARTICLE; CONTROLLED STUDY; CYP1A1 GENE; ENZYME REGULATION; GENE INDUCTION; GENE TARGETING; HEPATOCELLULAR CARCINOMA CELL LINE; HUH 7 CELL; HUMAN; HUMAN CELL; HUMAN TISSUE; LIVER METABOLISM; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN RNA BINDING; PROTEIN STRUCTURE; RECEPTOR DOWN REGULATION; RNA ANALYSIS; RNA EDITING; RNA SEQUENCE; RNA TRANSCRIPTION; XENOBIOTIC METABOLISM; BIOLOGICAL MODEL; DOWN REGULATION; GENE SILENCING; GENETICS; LIVER; METABOLISM; MOLECULAR GENETICS; NUCLEOTIDE SEQUENCE; TRANSCRIPTION INITIATION; TUMOR CELL LINE;

3' UNTRANSLATED REGIONS; ADENOSINE DEAMINASE; BASE SEQUENCE; BASIC HELIX-LOOP-HELIX TRANSCRIPTION FACTORS; CELL LINE, TUMOR; DOWN-REGULATION; GENE KNOCKDOWN TECHNIQUES; GENE SILENCING; HUMANS; LIVER; MICRORNAS; MODELS, BIOLOGICAL; MOLECULAR SEQUENCE DATA; RECEPTORS, ARYL HYDROCARBON; RNA EDITING; RNA, MESSENGER; RNA-BINDING PROTEINS; TRANSCRIPTIONAL ACTIVATION;

EID: 84954108309     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.M115.699363     Document Type: Article

References (42)

1. Wagner, R. W., Smith, J. E., Cooperman, B. S., and Nishikura, K. (1989) A double-stranded RNA unwinding activity introduces structural alterations by means of adenosine to inosine conversions in mammalian cells and Xenopus eggs. Proc. Natl. Acad. Sci. U.S.A. 86, 2647-2651
2. Gallo, A., and Galardi, S. (2008) A-to-I RNA editing and cancer: from pathology to basic science. RNA Biol. 5, 135-139
3. Farajollahi, S., and Maas, S. (2010) Molecular diversity through RNA editing: a balancing act. Trends Genet. 26, 221-230
4. Kim, U., Wang, Y., Sanford, T., Zeng, Y., and Nishikura, K. (1994) Molecular cloning of cDNA for double-stranded RNA adenosine deaminase, a candidate enzyme for nuclear RNA editing. Proc. Natl. Acad. Sci. U.S.A. 91, 11457-11461
5. Gerber, A., O'Connell, M. A., and Keller, W. (1997) Two forms of human double-stranded RNA-specific editase 1 (hRED1) generated by the insertion of an Alu cassette. RNA 3, 453-463
6. Bass, B. L., Nishikura, K., Keller, W., Seeburg, P. H., Emeson, R. B., O'Connell, M. A., Samuel, C. E., and Herbert, A. (1997) A standardized nomenclature for adenosine deaminases that act on RNA. RNA 3, 947-949
7. Nishikura, K. (2010) Functions and regulation of RNA editing by ADAR deaminases. Annu. Rev. Biochem. 79, 321-349
8. Patterson, J. B., and Samuel, C. E. (1995) Expression and regulation by interferon of a double-stranded-RNA-specific adenosine deaminase from human cells: evidence for two forms of the deaminase. Mol. Cell. Biol. 15, 5376-5388
9. Desterro, J. M., Keegan, L. P., Lafarga, M., Berciano, M. T., O'Connell, M., and Carmo-Fonseca, M. (2003) Dynamic association of RNA-editing enzymes with the nucleolus. J. Cell Sci. 116, 1805-1818
10. Slotkin, W., and Nishikura, K. (2013) Adenosine-to-inosine RNA editing and human disease. Genome Med. 5, 105
11. Chan, T. H., Lin, C. H., Qi, L., Fei, J., Li, Y., Yong, K. J., Liu, M., Song, Y., Chow, R. K., Ng, V. H., Yuan, Y. F., Tenen, D. G., Guan, X. Y., and Chen, L. (2014) A disrupted RNA editing balance mediated by ADARs (Adenosine DeAminases that act on RNA) in human hepatocellular carcinoma. Gut 63, 832-843
12. Bartel, D. P. (2004) MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116, 281-297
13. Ramadoss, P., Marcus, C., and Perdew, G. H. (2005) Role of the aryl hydrocarbon receptor in drug metabolism. Expert Opin. Drug Metab. Toxicol. 1, 9-21
14. Iwanari, M., Nakajima, M., Kizu, R., Hayakawa, K., and Yokoi, T. (2002) Induction of CYP1A1, CYP1A2, and CYP1B1 mRNAs by nitropolycyclic aromatic hydrocarbons in various human tissue-derived cells: chemical-, cytochrome P450 isoform-, and cell-specific differences. Arch. Toxicol. 76, 287-298
15. Tsuchiya, Y., Nakajima, M., Kyo, S., Kanaya, T., Inoue, M., and Yokoi, T. (2004) Human CYP1B1 is regulated by estradiol via estrogen receptor. Cancer Res. 64, 3119-3125
16. Mohri, T., Nakajima, M., Fukami, T., Takamiya, M., Aoki, Y., and Yokoi, T. (2010) Human CYP2E1 is regulated by miR-378. Biochem. Pharmacol. 79, 1045-1052
17. Nakano, M., Mohri, T., Fukami, T., Takamiya, M., Aoki, Y., McLeod, H. L., and Nakajima, M. (2015) Single-nucleotide polymorphisms in cytochrome P450 2E1 (CYP2E1) 3′-untranslated region affect the regulation of CYP2E1 by miR-570. Drug Metab. Dispos. 43, 1450-1457
18. Davarinos, N. A., and Pollenz, R. S. (1999) Aryl hydrocarbon receptor imported into the nucleus following ligand binding is rapidly degraded via the cytosplasmic proteasome following nuclear export. J. Biol. Chem. 274, 28708-28715
19. Ma, Q., and Baldwin, K. T. (2000) 2,3,7,8-Tetrachlorodibenzo-p-dioxin-induced degradation of aryl hydrocarbon receptor (AhR) by the ubiquitinproteasome pathway: role of the transcription activation and DNA binding of AhR. J. Biol. Chem. 275, 8432-8438
20. Paschen, W., Schmitt, J., and Uto, A. (1996) RNA editing of glutamate receptor subunits GluR2, GluR5, and GluR6 in transient cerebral ischemia in the rat. J. Cereb. Blood Flow Metab. 16, 548-556
21. Chen, L., Li, Y., Lin, C. H., Chan, T. H., Chow, R. K., Song, Y., Liu, M., Yuan, Y. F., Fu, L., Kong, K. L., Qi, L., Li, Y., Zhang, N., Tong, A. H., Kwong, D. L., Man, K., Lo, C. M., Lok, S., Tenen, D. G., and Guan, X. Y. (2013) Recoding RNA editing of AZIN1 predisposes to hepatocellular carcinoma. Nat. Med. 19, 209-216
22. Levanon, E. Y., Eisenberg, E., Yelin, R., Nemzer, S., Hallegger, M., Shemesh, R., Fligelman, Z. Y., Shoshan, A., Pollock, S. R., Sztybel, D., Olshansky, M., Rechavi, G., and Jantsch, M. F. (2004) Systematic identification of abundant A-to-I editing sites in the human transcriptome. Nat. Biotechnol. 22, 1001-1005
23. Peng, Z., Cheng, Y., Tan, B.C., Kang, L., Tian, Z., Zhu, Y., Zhang, W., Liang, Y., Hu, X., Tan, X., Guo, J., Dong, Z., Liang, Y., Bao, L., and Wang, J. (2012) Comprehensive analysis of RNA-Seq data reveals extensive RNA editing in a human transcriptome. Nat. Biotechnol. 30, 253-260
24. Wang, Q., Hui, H., Guo, Z., Zhang, W., Hu, Y., He, T., Tai, Y., Peng, P., and Wang, L. (2013) ADAR1 regulates ARHGAP26 gene expression through RNA editing by disrupting miR-30b-3p and miR-573 binding. RNA 19, 1525-1536
25. Yang, W., Chendrimada, T. P., Wang, Q., Higuchi, M., Seeburg, P. H., Shiekhattar, R., and Nishikura, K. (2006) Modulation of microRNA processing and expression through RNA editing by ADAR deaminases. Nat. Struct. Mol. Biol. 13, 13-21
26. Kawahara, Y., Megraw, M., Kreider, E., Iizasa, H., Valente, L., Hatzigeorgiou, A. G., and Nishikura, K. (2008) Frequency and fate of microRNA editing in human brain. Nucleic Acids Res. 36, 5270-5280
27. Kawahara, Y., Zinshteyn, B., Sethupathy, P., Iizasa, H., Hatzigeorgiou, A. G., and Nishikura, K. (2007) Redirection of silencing targets by adenosine-to-inosine editing of miRNAs. Science 315, 1137-1140
28. Liang, H., and Landweber, L. F. (2007) Hypothesis: RNA editing of microRNA target sites in humans? RNA 13, 463-467
29. Borchert, G. M., Gilmore, B. L., Spengler, R. M., Xing, Y., Lanier, W., Bhattacharya, D., and Davidson, B. L. (2009) Adenosine deamination in human transcripts generates novel microRNA binding sites. Hum. Mol. Genet. 18, 4801-4807
30. Wang, I. X., So, E., Devlin, J. L., Zhao, Y., Wu, M., and Cheung, V. G. (2013) ADAR regulates RNA editing, transcript stability, and gene expression. Cell Rep. 5, 849-860
31. Källman, A. M., Sahlin, M., and Ohman, M. (2003) ADAR2 A3I editing: site selectivity and editing efficiency are separate events. Nucleic Acids Res. 31, 4874-4881
32. Bazak, L., Levanon, E. Y., and Eisenberg, E. (2014) Genome-wide analysis of Alu editability. Nucleic Acids Res. 42, 6876-6884
33. Lehmann, K. A., and Bass, B. L. (2000) Double-stranded RNA adenosine deaminases ADAR1 and ADAR2 have overlapping specificities. Biochemistry 39, 12875-12884
34. Riedmann, E. M., Schopoff, S., Hartner, J. C., and Jantsch, M. F. (2008) Specificity of ADAR-mediated RNA editing in newly identified targets. RNA 14, 1110-1118
35. Polson, A. G., and Bass, B. L. (1994) Preferential selection of adenosines for modification by double-strandedRNAadenosine deaminase.EMBOJ. 13, 5701-5711
36. Ma, J., Lin, J., Qian, J., Qian, W., Yin, J., Yang, B., Tang, Q., Chen, X., Wen, X., Guo, H., and Deng, Z. (2014) MiR-378 promotes the migration of liver cancer cells by down-regulating Fus expression. Cell Physiol. Biochem. 34, 2266-2274
37. Jeon, T. I., Park, J. W., Ahn, J., Jung, C. H., and Ha, T. Y. (2013) Fisetin protects against hepatosteatosis in mice by inhibiting miR-378. Mol. Nutr. Food Res. 57, 1931-1937
38. Kurtz, C. L., Fannin, E. E., Toth, C. L., Pearson, D. S., Vickers, K. C., and Sethupathy, P. (2015) Inhibition of miR-29 has a significant lipid-lowering benefit through suppression of lipogenic programs in liver. Sci. Rep. 5, 12911
39. Roderburg, C., Urban, G. W., Bettermann, K., Vucur, M., Zimmermann, H., Schmidt, S., Janssen, J., Koppe, C., Knolle, P., Castoldi, M., Tacke, F., Trautwein, C., and Luedde, T. (2011) Micro-RNA profiling reveals a role for miR-29 in human and murine liver fibrosis. Hepatology 53, 209-218
40. Pierre, S., Chevallier, A., Teixeira-Clerc, F., Ambolet-Camoit, A., Bui, L. C., Bats, A. S., Fournet, J. C., Fernandez-Salguero, P., Aggerbeck, M., Lotersztajn, S., Barouki, R., and Coumoul, X. (2014) Aryl hydrocarbon receptor-dependent induction of liver fibrosis by dioxin. Toxicol. Sci. 137, 114-124
41. Hayashi, S., Watanabe, J., Nakachi, K., Eguchi, H., Gotoh, O., and Kawajiri, K. (1994) Interindividual difference in expression of human Ah receptor and related P450 genes. Carcinogenesis 15, 801-806
42. Paz, N., Levanon, E. Y., Amariglio, N., Heimberger, A. B., Ram, Z., Constantini, S., Barbash, Z.S., Adamsky, K., Safran, M., Hirschberg, A., Krupsky, M., Ben-Dov, I., Cazacu, S., Mikkelsen, T., Brodie, C., Eisenberg, E., and Rechavi, G. (2007) Altered adenosine-to-inosine RNA editing in human cancer. Genome Res. 17, 1586-1595